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        Introduction 
  Epilepsy is a chronic neurological disorder affecting 1  –  3% of 
mankind. It is defi  ned by recurrent spontaneous seizures that 
may be generated by synchronous fi  ring of a localized group of 
neurons, the so-called epileptic foci (  Engel, 1996  ;   Pitkanen and 
Sutula, 2002  ). Temporal lobe epilepsy (TLE) is the most com-
mon type of epilepsy in adults. It is characterized by the pres-
ence of epileptic foci located within the hippocampal formation, 
amygdala, or temporal neocortex. Unfortunately, in as many as 
70% of patients, TLE is intractable by pharmacologic treatment 
and requires brain surgery for seizure control. Accordingly, 
there is an urgent need to understand the molecular mechanisms 
of this severe disease. Aberrant synaptic plasticity has been postu-
lated to underlie formation of epileptic foci and, thus, molecules 
implicated in plasticity offer an interesting clue toward under-
standing the disease. 
  Matrix metalloproteinases (MMPs) form a large family of 
structurally related zinc-dependent secreted or cell membrane  –
  bound proteinases that are considered to be major executors of 
ECM remodeling throughout the body (  Sternlicht and Werb, 
2001  ) and of pivotal importance in cancer invasion and metas-
tasis. In the adult brain, MMPs have repeatedly been implicated 
in various pathologies, including acute and chronic neuro-
degeneration (e.g., in ischemia, trauma, and Alzheimer  ’  s disease), 
infl  ammation, and cancer (for review see   Yong, 2005  ). Recent 
studies also suggest that MMP-9 plays an important role in syn-
aptic plasticity, learning, and memory (  Szklarczyk et al., 2002  ; 
  Meighan et al., 2006  ;   Nagy et al., 2006  ;   Okulski et al., 2007  ; 
  Tian et al., 2007  ). As epileptogenic plasticity involves extensive 
nervous tissue remodeling ( Ben-Ari, 2001 ), we decided to examine 
the potential pathogenic role of MMP-9 in two distinct animal 
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  When we performed PTZ kindling on MMP-9 KO mice 
and wild-type (WT) controls, no difference was noted in con-
vulsive behavior upon the fi  rst injections (  Fig. 1 A  ). Sub-
sequently, when WT mice started to respond with seizures, 
many MMP-9 KO animals remained insensitive to PTZ. MMP-9  –
 defi  cient mice eventually developed seizures that progressively 
increased in score, but the seizures remained less severe than in 
WT mice (repeated measures analysis of variance [ANOVA]: 
F(1,9) = 9.9; P   <   0.05). Finally, there was also a difference in 
survival rate. Thus three out of fi  ve WT and one out of six KO 
died upon generalized seizures during the last phase of the ex-
periment (sign test; P   <   0.05;   Fig. 1 A  ). 
 Having  identifi  ed a protective effect of MMP-9 gene KO, 
we then asked whether overexpression of MMP-9 would en-
hance epileptogenesis. To this end, we generated transgenic 
(TG) rats with constitutive neuronal MMP-9 overexpression 
  under the control of the synapsin I promoter (MMP-9 TG). This 
procedure resulted in a markedly increased MMP-9 expression 
and activity in the brain but not in other organs (Fig. S1, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200708213/DC1). 
When we subjected MMP-9 TG rats to PTZ kindling, we ob-
served an increased susceptibility to epileptogenesis as com-
pared with the WT rats (repeated measures ANOVA: F(1,13) = 4.9; 
P   <   0.05;   Fig. 1 B  ). Essentially the same results were obtained 
in another line of MMP-9  –  overexpressing TG rats that we gen-
erated (repeated measures ANOVA: F(1,15) = 5.7; P   <   0.05; 
not depicted). 
  MMP-9 is localized to hippocampal 
synapses and becomes up-regulated therein 
upon kainate-evoked seizures 
  We hypothesized that MMP-9 facilitated the development of 
seizures through an effect on epilepsy-related synaptic plasticity. 
As a fi  rst step toward the understanding of how MMP-9 exerts 
its infl  uence on dendritic spines, we investigated its fi  ne struc-
tural localization in the dendritic layer of the hippocampal DG 
in control and kainate-treated rats, using light and electron micro-
scopic immunocytochemistry. 
  In the control DG, confocal microscopy revealed punctate 
MMP-9 immunostaining throughout the dendritic (molecular) 
layer and, to a much lesser extent, throughout the layer of neuro-
nal cell bodies (  Fig. 2, A and B  ).    A high-power imaging of the 
DG dendritic fi  eld revealed that the majority (72   ±   7%) of 
MMP-9  –  immunoreactive foci strictly colocalized with den-
drites (as indicated by their overlap with a dendritic marker, 
MAP-2;   Fig. 2 C  ). Moreover, by labeling MMP-9 in conjunc-
tion with the presynaptic marker synaptophysin (  Fig. 2, D  –  G  , 
circles), the postsynaptic marker   N -methyl   d -aspartate  acid  re-
ceptor (NMDAR) subunit NR1 (  Fig. 2, H  –  J  , circles), or the den-
dritic spine protein drebrin (Fig. S2, available at http://www.jcb
.org/cgi/content/full/jcb.200708213/DC1), we found that many 
of the dendritic MMP-9  –  positive puncta overlapped with, or 
were located very close to, synapses. Interestingly, at very high 
magnifi  cation, synaptic MMP-9 immunoreactivity (IR) appeared 
to colocalize more extensively with NR1 than with synaptophy-
sin, which is consistent with an association with postsynaptic 
rather than presynaptic domains. 
models of TLE: kainate-evoked epilepsy and pentylenetetrazole 
(PTZ) kindling  –  induced epilepsy (for review see   Morimoto 
et al., 2004  ). 
  Kainate is a neurotoxic agonist of glutamate receptors that 
induces severe status epilepticus, leading to neurodegeneration 
in all hippocampal subfi  elds except for the dentate gyrus (DG; 
  Sperk, 1994  ). Instead of dying, the granule neurons of the DG 
undergo a sequence of plastic phenomena, including pruning of 
dendritic spines (  Suzuki et al., 1997  ) and axonal sprouting that 
involves ingrowth of mossy fi  bers (granule cell axons) into their 
parent dendritic fi  eld to make recurrent excitatory connections 
(  Sutula et al., 1998  ). The sprouting is believed to underlie spon-
taneous seizures that occur in kainate-treated animals after some 
latency period (for review see   Morimoto et al., 2004  ). It is of in-
terest to note that kainate strongly up-regulates MMP-9 in the 
DG (  Szklarczyk et al., 2002  ). 
  Kindling is a repeated electrical or chemical stimulation 
of the brain that initially does not induce seizures but eventually 
leads to lowering of the seizure threshold and, fi  nally, to the 
  occurrence of spontaneous seizures that are the hallmark of epi-
lepsy (for review see   Morimoto et al., 2004  ). Kindling is not 
associated with overt neurodegeneration, yet it induces excessive 
sprouting of mossy fi  bers and synaptogenesis, mainly within the 
mossy fi   bers ’   normal  terminal  fi  eld, i.e., at the CA3 pyramidal 
cells  ’   dendrites (  Chen and Strickland, 1997  ). 
  Importantly, mechanisms similar to those operating in 
kainate- and/or kindling-induced animal epilepsy occur during 
the course of TLE (albeit in a different time frame), as demon-
strated by autopsy studies of human epileptic brains (  Proper 
et al., 2000  ). 
  In this paper, using the MMP-9 gene knockout (KO), as 
well as a novel model of MMP-9 overexpression, we show 
that MMP-9 plays a major role in epileptogenesis. We further 
demon  strate that MMP-9 protein and enzymatic activity are up-
regulated in hippocampal synapses upon seizures, contributing 
to remodeling of dendritic spines and aberrant synaptogenesis. 
Our studies have clinical implications, as they identify MMP-9 
as a potential pharmacological target in epilepsy. 
  Results 
  MMP-9 facilitates chemical kindling  –  induced 
epilepsy in vivo 
 We  fi  rst asked whether deletion of the MMP-9 gene affects 
  epileptogenesis. To avoid any indirect effects of MMP-9 defi  -
ciency that could occur in the kainate model because of the well 
known role of MMP-9 in neuronal death (  Jourquin et al., 2003  ; 
for   review see   Yong, 2005  ), we decided to investigate a chemi-
cal kindling model that, in contrast to the kainate model, does 
not involve neurodegeneration. In the kindling model, animals 
are given repeated intraperitoneal injections of a subconvulsive 
dose of PTZ for several weeks. During the course of the experi-
ment, progressive lowering of seizure threshold occurs and the 
animals start to exhibit seizure behavior, which is aggravated 
with time (  Fig. 1 A  ).    At the end point of such a kindling proce-
dure, the dose that was subconvulsive at the beginning elicits 
full-blown generalized tonic-clonic seizures. 1023 MATRIX METALLOPROTEINASE 9 IN TEMPORAL LOBE EPILEPSY   •   WILCZYNSKI ET AL.
showing an increase in MMP-9 IR in the DG after kainate ad-
ministration (maximum at 72 h;   Szklarczyk et al., 2002  ). 
  After 24 h, the punctate MMP-9 IR became accompanied 
by MMP-9 labeling of glial cells (  Fig. 3 B  ). The glial labeling, 
which derived mainly from astrocytes (based on their IR for glial 
fi  brillary acidic protein [GFAP]; not depicted), increased there-
after, reaching its peak at 7 d after seizure onset (  Fig. 3 C  ). 
  Quantitative evaluation of MMP-9 and MAP-2 co-
localization in the DG molecular layer revealed that the number 
(per unit area) and fl  uorescence intensity of the dendrite-associ-
ated MMP-9  –  positive foci increased 5.6   ±   0.1-fold and 6.7   ±   
0.2-fold at 24 and 72 h after seizures, respectively (Kruskall-
Wallis test; P   <   0.05). No change was found in the mean area 
occupied by dendrites, which indicates that these changes could 
not result from the shrinkage of the tissue. To address the status 
of MMP-9 IR at the level of synapses, we used preembedding 
immunoelectron microscopy with silver enhancement of the 
peroxidase reaction product. No major qualitative changes in 
the pattern of MMP-9 IR were detected at the ultrastructural 
level at the 72-h time point, yet the number of MMP-9 IR  – 
containing spine profi  les per unit area increased by a factor of 
2.2   ±   0.1 (  t   test; P   <   0.05;   Fig. 3 M  ). 
  Synaptodendritic MMP-9 enzymatic 
activity increases after kainate treatment 
  After obtaining the immunocytochemical data, it became neces-
sary to determine whether synaptic MMP-9 is active and whether 
this activity is regulated by seizures. To this end, we performed 
both in situ and gel zymography of subcellular fractions to com-
pare control brains and brains of kainate-injected animals 24 h 
after the onset of seizures. We showed previously that kainate-
induced up-regulation of the bulk gelatinolytic activity peaks at 
this time point (  Szklarczyk et al., 2002  ). 
  To visualize gelatinolytic activity, we established a proto-
col in which 150-  μ  m thick acutely isolated hippocampal slices 
were incubated with a fl  uorogenic substrate (DQ gelatin) in the 
tissue culture incubator. The experiments demonstrated gelatin-
ase activity to be present in the cell bodies of granule neurons 
(not depicted) and in the neuropil of the molecular layer (  Fig. 4, 
A, C, D, and F  ).    In the latter, there were numerous discrete sub-
micrometer foci of enzymatic activity. Double labeling with 
anti  –  MAP-2 antibody revealed that the majority of those foci co-
localized with dendrites (  Fig. 4, C and F  , arrows). Kainate caused 
  To explore the subcellular MMP-9 distribution, we used a 
postembedding immunogold procedure that affords preserva-
tion of ultrastructural details as well as protein IR. By this tech-
nique, the majority of gold particles were found to be associated 
with a subset (    50%) of dendritic spine profi  les (  Fig. 2  ). Within 
MMP-9  –  immunoreactive spines, immunogold particles were 
present mainly in the spine head, frequently being located adja-
cent to, or within, postsynaptic densities (PSD) of axospinous 
(excitatory) synapses (  Fig. 2, Q, R, T, and U  ). Frequently, gold 
particles were associated with the spine plasma membrane, with 
some particles being superimposed on the synaptic cleft (  Fig. 2, 
Q, R, and T  ) and/or extracellular space (  Fig. 2, Q and V  ). Within 
spines, gold particles were often found in the vicinity of vesicu-
lar (  Fig. 2, T and V  ) or tubulovesicular (  Fig. 2 U  ) membrane 
structures. The quantitative analysis of the labeling density of 
spine profi  les (7.6   ×   10 
   6 /nm 
2 ;   n   = 92 spines) confi  rmed a sig-
nifi  cant association of gold particles with this compartment, as 
compared with both background density (0.4   ×   10 
   6 /nm 
2 ;     
2   = 
77.3; P   <   0.000001) and overall gold particle density (4.4   ×   
10 
   6 /nm 
2 ;     
2   = 26.1; P   <   0.000001; see Materials and methods 
for details) in the section. Interestingly, among spines contain-
ing MMP-9 IR, we found a strong negative correlation between 
the density of gold particles and area of spine profi   le  (Spearman ’ s 
rank correlation coeffi  cient:   r   = 0.72; P   <   0.05). 
  Clusters of gold particles were found not only in spines 
but also postsynaptic to asymmetrical synapses on dendritic 
stems (unpublished data). In contrast, the vast majority of axo-
dendritic symmetric (inhibitory) synapses were devoid of gold 
particles, signaling MMP-9 (  Fig. 2 V  ). We supported this fi  nd-
ing using less precise, albeit statistically much more robust, 
immuno fl  uorescent confocal analysis, showing virtually no co-
localization of MMP-9 IR with     2/3 GABA-AR subunits, 
which mark inhibitory synapses (  Fig. 2, K  –  M  ). Apart from syn-
aptic sites, MMP-9 IR was also located within vesicular struc-
tures in dendritic shafts (  Fig. 2 V  ) and in some small astrocytic 
processes (not depicted). 
  Kainate-induced status epilepticus produced profound 
changes in MMP-9 IR throughout the DG molecular layer that 
were noticeable over several days after insult. By light micros-
copy, the punctate MMP-9 IR became strongly increased at 24 h 
after seizure onset, peaked at 72 h (  Fig. 3, A  –  C  ), and remained 
increased at 7 d after insult.    Thus, we confi  rmed our previous 
results, obtained by immunohistochemistry and Western blotting, 
  Figure 1.       MMP-9 involvement in PTZ   kindling  –
  induced epilepsy.   Seizure scores of PTZ-kindled 
WT and MMP-9 KO mice (A) and WT and 
MMP-9  –  overexpressing TG rats (B) during the 
course of the experiment. Note that epilepto-
genesis is delayed in MMP-9 KO mice (re-
peated measures ANOVA: F(1,9) = 9.9; P   <   
0.05). In contrast, epileptogenesis is acceler-
ated in MMP-9  –  overexpressing TG rats (re-
peated measures ANOVA: F(1,13) = 4.9; P   <   
0.05). Note that the differences in the seizure 
score between WT and TG animals do not 
show up upon the ﬁ  rst few injections but pro-
gressively develop thereafter, thus indicating 
that a plastic process is involved. Error bars 
represent SEM.     JCB • VOLUME 180 • NUMBER 5 • 2008  1024
  Figure 2.       MMP-9 IR in the control DG.   (A and B) Low-power single-plane confocal images of MMP-9 IR (A) and MMP-9 IR plus MAP-2 IR (B, red and green, 
respectively) showing predominantly punctate MMP-9 IR in the DG molecular layer. Strong MMP-9 IR is also present within the walls of blood vessels in the 
stratum lacunosum moleculare (SLM). The anatomical subdivisions of the DG are marked as follows: IML, inner molecular layer; MML, middle molecular 
layer; OML, outer molecular layer; GL, granular layer. Bar, 75   μ  m. (C) High-power confocal image of the DG middle molecular layer double stained for 1025 MATRIX METALLOPROTEINASE 9 IN TEMPORAL LOBE EPILEPSY   •   WILCZYNSKI ET AL.
that MMP-9 KO renders dendritic spines signifi  cantly more re-
sistant to kainate-evoked pruning (  Fig. 5  ). Essentially the same 
results were obtained with another spine marker, fl  uorophore-
conjugated phalloidin (F-actin  –  specifi  c probe), used in conjunc-
tion with the PSD marker ProSAP/Shank (  Fig. 5, G  –  O  ). Again, 
in MMP-9  –  defi  cient mice, the phalloidin staining of spines was 
signifi  cantly less affected than in WT mice. The spine counts in 
untreated WT and KO mice did not differ from each other. 
  MMP-9 activity is involved in aberrant 
synaptogenesis after mossy ﬁ  ber sprouting 
  Epileptogenesis in the kainate-treated hippocampus begins within 
    1 wk after the insult when sprouting mossy fi  bers start to make 
recurrent synapses with granule cell dendrites (  Suzuki et al., 
1997  ;   Sutula et al., 1998  ;   Ben-Ari, 2001  ). To test whether MMP-9 
activity may play a role in aberrant synaptogenesis, we fi  rst used 
rat organotypic hippocampal slices subjected either to kainate 
excitotoxicity or picrotoxin stimulation and treated with a spe-
cifi  c MMP-9 inhibitor. 
  Organotypic hippocampal cultures retain the typical ana-
tomical features of the hippocampal formation, thus providing 
an excellent model to study the effects of various molecules on 
hippocampal structure and function (  Jourquin et al., 2003  ). 
We treated such cultures with either kainate or vehicle solution. 
The cultures were then allowed to recover for 2 wk, after which 
they were fi  xed and immunostained for synaptoporin, a marker 
of mossy fi  ber boutons. Additionally, the cultures were costained 
for MAP2 to visualize dendrites. This procedure helped also to 
delineate anatomical subdivisions (Fig. S1). In control cultures, 
there was an intense synaptoporin IR of the mossy fi  ber path-
way (extending from the dentate hilus up to the end of the CA3 
area) but little or no synaptoporin labeling in the DG granular 
and inner molecular layers (  Fig. 6 A   and Fig. S1).    Kainate treat-
ment at DIV (day in vitro) 9 caused an extensive neurodegener-
ation (indicated by the loss of MAP2 staining) with a pattern 
similar to that found in vivo (CA affected, DG spared). The 
damage was fully developed by 24 h. Importantly, when such 
cultures were examined at 21 DIV, a dense meshwork of strongly 
synaptoporin-positive terminals appeared among the granule 
cells bodies and in their dendritic fi  eld, which is indicative of 
robust mossy fi  bers sprouting (  Fig. 6, B and H  ; and Fig. S1). 
a dramatic increase in the number of dendritic gelatinase spots 
( Fig.  4 ,  compare   C   and   F ). 
 Gel zymography of subcellular fractions from control hippo-
campi revealed substantial MMP-9 and MMP-2 activities in 
  total homogenate, but no gelatinase activity was found in the 
synaptodendrosomal fraction of this sample (  Fig. 4 G  ). Kainate 
treatment caused an up-regulation of MMP-9, but not MMP-2, 
in total homogenate and the emergence of a single band of an 
apparently latent form of MMP-9, but not MMP-2, activity in 
synaptodendrosomes. Lack of activated MMP-9 (of smaller 
molecular weight) appears surprising; however, it may result from 
a washout of the active secreted protein during the biochemical 
procedure. It is unlikely that 24 h after the kainate treatment only 
pro  –  MMP-9 is present at the synapses because the activity 
clearly shows up in in situ zymography without the SDS treat-
ment that activates the latent MMP-9. However, it should also be 
noted that a latent form of MMP-9 has been suggested to have 
some gelatinolytic activity in vivo (  Bannikov et al., 2002  ). 
  Seizure-induced dendritic spine pruning 
involves MMP-9 
  To investigate whether MMP-9 is functionally involved in seizure-
induced spine pruning, we decided to compare the degree of 
acute spine loss in kainate-treated MMP-9 WT and KO mice. 
Because MMP-9 KO mice are resistant to the excitotoxic effect of 
intraperitoneally administered kainate (unpublished data), prob-
ably because of their C57BL/6 genetic background (  McKhann 
et al., 2003 ), we made unilateral kainate injections into the amyg-
dala (according to   Wu et al. [2000]  ) that did result in status epi-
lepticus, followed by characteristic hippocampal CA1-CA3 and 
hilar degeneration on the injected, but not contralateral, side. 
  We analyzed in this model the effect of kainate on the 
spine density in the DG molecular layer of MMP-9 WT and KO 
mice using Golgi silver impregnation. In WT animals, we found 
that at 24 h after the onset of seizures, a substantial decrease in 
the density of spines occurred at the injected side as compared 
with the contralateral side (  Fig. 5 U  ).    In striking contrast, there 
was no statistically signifi  cant difference between the injected 
and contralateral side in MMP-9 KO mice (  Fig. 5 U  ). Impor-
tantly, there were no apparent differences between WT and KO 
animals in regard to the intensity of seizures. Thus, it appears 
MMP-9 (red) and MAP-2 (green). Bar, 1   μ  m. (insets 1  –  5) The majority of MMP-9  –  immunoreactive puncta strictly colocalize with dendrites. Bar, 5   μ  m. (D  –  G) High-
power triple immunolabeling for MMP-9 (D; and G, red), MAP-2 (E; and G, green), and synaptophysin (F; and G, blue; parafﬁ  n section). Note that 
dendrite-associated MMP-9  –  immunoreactive foci frequently lie adjacent to synaptophysin puncta, which represent presynaptic terminals. Circles indicate 
the sites of triple colocalization, i.e., putative MMP-9  –  immunoreactive synapses. SYN, synaptophysin. Bar, 2   μ  m. (H  –  M) High-power double immunolabeling 
for MMP-9 (H; J, red; K; and M, red) and either NR1 (I; and J, green) or GABA-R subunits     2/3 (L; and M, green; parafﬁ  n sections). Although some of 
the MMP-9  –  immunoreactive spots colocalize with NR1 (H  –  J, circles), virtually none of them colocalize with GABA-R. Bars, 1   μ  m. (N  –  P) Control specimen 
double immunolabeled for synaptophysin (N; and P, red) and the postsynaptic marker drebrin (O; and P, green), the proteins which are known not to co-
localize. DREB, drebrin. Bar, 1   μ  m. (Q  –  V) Electron microscopic immunogold detection (after embedding) of MMP-9 in the DG molecular layer. The following 
ultrastructural landmarks are shown: SPINE  ,   dendritic spine; B, presynaptic bouton; and SYM, symmetric synapse. Immunogold particles indicating MMP-9 
IR are present at dendritic spines (Q  –  V) and thin shafts (V), where they associate with the plasma membrane (red arrowheads), including the postsynaptic 
membrane of asymmetrical (excitatory) synapses (R and T, red arrowheads), and with the cytoplasmic vesicular or tubulovesicular structures (T  –  V, blue 
  arrowheads). Note the immunonegative symmetric (inhibitory) dendritic shaft synapse (V, inset, SYM). Bars: (R and T) 100 nm; (Q,S,V, and inset) 200 nm; 
(U) 50 nm. (W) A scatterplot demonstrating the relationship between the size of dendritic spine proﬁ  le (area of cross section; x axis) and the concentration 
of MMP-9 IR it contains (approximated by the ratio between the number of gold particles found within the spine cross section and the area of this cross 
section; y axis). Each spine proﬁ  le is represented by dots. Blue dots, synapses that contained at least one gold particle; purple dots, immunonegative 
spine proﬁ  les. Curve ﬁ  tting reveals the essentially exponential form of the relationship among immunoreactive proﬁ  les (red line). The horizontal green line 
represents the background labeling (0.4   ×   10 
    6  /nm 
2  ) estimated over the ultrastructural compartment that had the lowest gold density, i.e., the cytoplasm 
of large dendritic proﬁ  les.     
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tures but the intensity of synaptogenesis was not as pronounced. 
There was no loss of MAP-2 staining, indicating absence of 
neurodegenerative changes (unpublished data). However, as in the 
experiment with kainate, picrotoxin-evoked sprouting was at-
tenuated by administration of the MMP-9 inhibitor (  Fig. 6 S  ). 
  Finally, we asked whether the reduced susceptibility of 
MMP-9 KO mice to PTZ kindling in vivo is associated with an 
attenuation of aberrant synaptogenesis. We subjected the brains 
of the PTZ-kindled mice to synaptoporin immunocytochemistry 
(  Fig. 6, U and V  ) and found that the hippocampi of MMP-9 
KO animals displayed signifi  cantly less mossy fi  ber synapto-
genesis in the CA3 area than did hippocampi of WT mice (  Fig. 6  , 
compare U, V, and W). 
  Discussion 
  Thus far, ion channels and receptors have been center stage in 
epilepsy research. Little attention has been paid to the possibil-
ity that extracellular proteinases are critically involved in the 
development of epilepsy. In this paper, we present the novel 
fi  nding that experimental manipulations of the level and activity 
of MMP-9 signifi  cantly affect the susceptibility to epileptogen-
esis in two commonly used models of epilepsy. Most notably, 
lack of MMP-9 in the KO mice and overexpression of its activ-
ity in the TG rats produce opposite effects on epileptogenesis. 
In contrast, when a specifi  c MMP-9 inhibitor, S24994 (  Hanessian 
et al., 2001  ), was applied after kainate, there was virtually no 
synaptoporin immunolabeling and, thus, apparently no sprout-
ing (  Fig. 6, C and I  ; and Fig. S1). Quantitative assessment of 
the high-resolution images of the DG revealed that MMP-9 
inhibition resulted in an   90% decrease in the density of sprout-
ing mossy fi  ber terminals (  Fig. 6 T  ). Importantly, in our experi-
mental setup, MMP-9 inhibition had only little (if any) infl  uence 
on the fi  nal extent of kainate-mediated damage (Fig. S1). Thus, 
we could rule out possible indirect effects of MMP-9 in-
hibition on sprouting/synaptogenesis, e.g., through promotion 
of CA3 cell survival (alleviation of triggering stimuli). Nota-
bly, although there was signifi  cant variability of neuronal dam-
age among the cultures, the MMP-9 inhibitor was similarly 
effective in all of them in regard to its ability to counteract mossy 
fi  ber sprouting. 
  To further avoid potentially confounding effects of excito-
toxic activity of kainate, we studied the effect of S24994 in cul-
tures grown in the presence of picrotoxin (a GABA  A   receptor 
antagonist), a compound known to induce sprouting without 
causing cell damage (  Koyama et al., 2004  ). Examined after 10 
DIV, the cultures treated with picrotoxin had very strong punc-
tate synaptoporin IR throughout the DG granule cell and mo-
lecular layers (  Fig. 6, K and R  ). The overall pattern of aberrant 
synaptogenesis was very similar to that of kainate-treated cul-
  Figure 3.       MMP-9 IR after kainate treatment.   (A and B) Low-power 
confocal images of MMP-9 IR in the DG molecular layer in con-
trol brain (A) and 72 h after seizures (B). Bar, 75   μ  m. In B, note 
strongly increased granular IR. In addition, there is labeling of glial 
cells (mainly astrocytes, as indicated by their GFAP positivity; not de-
picted). (C) The densities of MMP-9  –  immunoreactive foci colocalizing 
with dendrites in the DG molecular layer at various time-points after 
seizures. Quantitative confocal evaluation of the specimens double 
immunostained for MMP-9 and MAP-2. Asterisk indicates signiﬁ  cant 
difference (Kruskall-Wallis test; P   <   0.05). Error bars represent SEM. 
(D  –  K) High-power view of the DG neuropil (middle molecular layer) 
immunostained for MMP-9 (D and H; and G and K, red), NR1 (E 
and I; and G and K, blue), and synaptophysin (F and J; and G and 
K, green) in control (D  –  G) and at 72 h after seizures (H  –  K). The 
number of MMP-9  –  positive synapses (circles, red-blue-green objects) 
increases prominently after kainate. The MMP-9 signal in A, B, and 
D  –  K was acquired using the photomultiplier sensitivity that was opti-
mized to cover the maximum range of signal intensity at the 72-h time 
point after kainate, resulting in an apparently lower signal in controls 
(A and D) compared with   Fig. 2  . Bars, 5   μ  m. (L and M) Electron micro-
scopic visualization (L) and quantiﬁ  cation (M) of MMP-9 IR in den-
dritic spines in control and 72 h after seizures, using preembedding 
procedure with silver-enhanced diaminobenzidine. There is a promi-
nent increase in the frequency of positive dendritic spine proﬁ  les in 
the sections from kainate-treated animals. Asterisk indicates statistical 
signiﬁ  cance (  t   test; P   <   0.05). Error bars represent SEM.     1027 MATRIX METALLOPROTEINASE 9 IN TEMPORAL LOBE EPILEPSY   •   WILCZYNSKI ET AL.
an important role in the processes that lead to the development 
of recurrent epileptic seizures and the associated plasticity. 
  In a seminal study by   Nedivi et al. (1993)  , TIMP1, an 
  endogenous inhibitor of MMPs, was listed among several 
genes that were found to be up-regulated by kainate treatment 
specifi  cally in the DG. We pursued this intriguing fi  nding by 
demonstrating that TIMP1 was in fact a neuronal target of the 
activity-dependent transcription factor AP1 ( Jaworski et al., 1999 ) 
and was up-regulated by seizures throughout the entire hippo-
campus. Next, while searching for a physiological signifi  cance 
of TIMP1 up-regulation, we found that kainate also caused a 
very prominent increase in neuronal MMP-9 that followed a 
similar spatiotemporal pattern and occurred at the levels of 
both gene expression and enzymatic activity (  Szklarczyk et al., 
2002  ). Although there is evidence that excitation-driven MMP-9 
activation can be deleterious to neurons (  Jourquin et al., 2003  ), 
this cannot apply to DG granule cells, which are known to sur-
vive even the very intense kainate-evoked status epilepticus 
(  Sperk, 1994  ). Thus, we hypothesized that the prolonged MMP-9 
up-regulation in the DG after status epilepticus represents an 
insult-related plastic response. This brings to the fore the ques-
tion of what effects MMP-9 actually exerts at the cellular and 
subcellular levels upon its up-regulation by seizures. Because 
the postkainate changes occurring at the DG dendritic tree can 
be divided (somewhat arbitrarily) as falling into two phases, the 
early spine pruning and subsequent chronic progressive (aber-
rant) synaptogenesis, we searched for possible MMP-9 func-
tions accordingly. Furthermore, after obtaining evidence that 
MMP-9 is involved in epileptogenesis in a kainate model, we 
investigated another model, pharmacological kindling, using 
TG mice and rats. Through this approach, we were able to show 
that the pivotal role of MMP-9 in epileptogenesis is not limited 
to a particular species or experimental model. 
  In our studies we have made extensive use of the MMP-9 
KO mice. Such a model may be biased by compensatory ef-
fects, such as an overexpression of functionally related protein. 
Therefore, we provided additional support for our conclusions 
by analysis of MMP-9  –  overexpressing TG rats. Notably, the 
chemically kindled TG rats displayed a phenotype opposite to 
that of the MMP-9 KO mice in regard to epileptogenesis. 
  One could argue that the resistance of MMP-9  –  defi  cient 
mice to kainate-induced synaptogenesis in the DG results from 
their lower sensitivity to the excitotoxic action of kainate. In fact, 
in our initial analysis of an MMP-9  –  defi  cient mouse treated 
with intraamygdalar kainate injections, we noticed a consider-
able reduction in the extent of neurodegeneration (as compared 
with WT animals) at 3 wk after the kainic acid (KA) injection. 
However, using organotypic slice cultures, we were able to con-
clude that MMP-9 directly affects kainate-induced synaptogen-
esis, as the MMP-9 inhibitor had no effect on neuronal damage 
in this model yet signifi  cantly reduced mossy fi  ber sprouting. 
Our experiments with picrotoxin (which induces mossy fi  ber 
sprouting but no cell damage) support the conclusion that the effect 
of MMP-9 on sprouting is direct rather than mediated through 
an effect on cell damage. Likewise, the effect of MMP-9 on the 
development of epilepsy in vivo can be dissociated from any neuro-
pathological consequences of MMP-9 KO or overexpression, 
The MMP-9  –  overexpressing TG rats are reported herein for the 
fi  rst time. We also explore the mechanisms involved and demon-
strate that the same changes in MMP-9 gene expression that 
regulate epileptogenesis also modify epilepsy-associated syn-
aptic plasticity, including dendritic pruning and mossy fi  ber 
sprouting. By the use of high-resolution immunogold cyto-
chemistry, we identifi  ed a novel synaptic pool of MMP-9 and 
showed that this pool increased in response to kainate treat-
ment. Collectively, our data strongly suggest that MMP-9 plays 
  Figure 4.       Zymographic analysis of gelatinase activity.   (A  –  F) High-resolution 
ﬂ  uorescence in situ zymography (A, B, D, and E, single-plane single-
  channel confocal images; C and F, respective overlays) shows that 
  gelatinase foci (A and D; and C and F, green) frequently colocalize with 
dendrites (C and F, arrows) and are increased after kainate (compare 
control [A] and 24 h of kainate [KA 24 h; D]). Bar, 5   μ  m. (G) Gel zymog-
raphy of hippocampal subcellular fractions. HOMOG, total homogenate; 
SYNAPT, synaptodendrosomal fraction. Top bands, MMP-9 activity; bot-
tom band, MMP-2 activity. No MMP-9 activity is present in control syn-
aptodendrosomes. Kainate treatment results in de novo appearance of 
the prominent band corresponding to synaptodendrosomal (pro  –  ) MMP-9 
activity. MMP-2 activity does not change after kainate and is absent from 
synaptodendrosomal fractions. The MMP-2 band should be considered as 
an internal control.     JCB • VOLUME 180 • NUMBER 5 • 2008  1028
  To determine the fi  ne-structural localization of MMP-9, 
we used a variety of complementary approaches, including light 
and electron microscopic immunocytochemistry (with the use 
of two different MMP-9  –  specifi  c antibodies), high-resolution 
in situ zymography, and subcellular fractionation. These ap-
proaches concurred to support an association of MMP-9 with 
dendritic spines in both naive and stimulated brain. Importantly, 
our electron microscopic analysis demonstrated that MMP-9 
up-regulation after seizures occurred in the very same popula-
tion of spines that underwent pruning (the same population was 
protected in MMP-9 KO). These are novel observations that 
force us to revise the current concepts regarding the roles of 
as the PTZ model (unlike the kainate model) does not show sig-
nifi  cant cell damage in the central nervous system. 
  Our unpublished electrophysiological observations indi-
cate that when used alone, the specifi  c MMP-9 inhibitor S24994 
does not cause any gross changes in the electrical activity of the 
nervous tissue. Therefore, it is very unlikely that the effect of 
inhibitor was indirect, e.g., through modifying electrical epilepto-
genic activity. The different experimental approaches provided 
consistent results and are in agreement with  Reeves et al. (2003) , 
who demonstrated a benefi  cial effect of a general MMP inhibi-
tor on the histological and behavioral outcome in an animal 
model of trauma-induced aberrant synaptic plasticity. 
  Figure 5.       The analysis and visualization of 
dendritic spines in MMP-9 KO and WT mice 
at 24 h after intraamygdalar KA injection.   
(A  –  C) Representative ﬁ   elds of Golgi-stained 
hippocampal granule cell dendrites of the DG 
middle molecular layer in control (A) and kainate-
treated (B and C) WT (A and B) and KO (C) 
mice. Bar, 50   μ  m. (D  –  F) 3D higher-resolution 
reconstruction of the segments shown in A  –  C 
in white rectangles. Note the striking differ-
ence in the prevalence of dendritic spines 
(arrowheads) between control and kainate-
treated WT brain (D vs. E). Also note that the 
density of spines in the kainate-treated KO 
animal is similar to that of the untreated WT. 
(G  –  S) Representative dendritic segments from 
untreated (G  –  I) and kainate-treated (J  –  S) WT 
(J  –  L) and KO (M  –  S) animals stained with rho-
damine phalloidin (red) and MAP-2 (green). 
Bar, 5   μ  m. Note that seizure-evoked loss of 
F-actin  –  positive dendritic spines (compare I 
and L) is virtually absent in the MMP-9 KO ani-
mal (compare I and O). (P  –  S) An area from 
O (white rectangle) showing colocalization 
of F-actin (red) and PSD-associated ProSAP/
Shank protein (blue) that proves the identity of 
dendritic spines. The purple in the overlay indi-
cates colocalization. (T and U) Dendritic spine 
counts (T) in untreated and injected MMP-9 
WT and KO mice and estimates of dendritic 
spine loss (U) at the injected side (relative to 
the contralateral side) at 24 h after unilateral 
intraamygdalar kainate injection. Asterisk indi-
cates statistical signiﬁ  cance (  t   test; P   <   0.05). 
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  Figure 6.       MMP-9 involvement in seizure-induced synaptogenesis.   (A  –  S) The effect of the speciﬁ  c MMP-9 inhibitor S24994 on mossy ﬁ  ber sprouting and 
aberrant synaptogenesis in the DG dendritic layer of the rat organotypic hippocampal cultures treated with either kainate (B, C, E, F, H, and I) or picro-
toxin (K, L, N, O, R, and S) or untreated (A, D, G, J, M, and P). High-power confocal micrographs (A  –  F and J  –  O, single channel; G  –  I and P  –  S, respective 
overlays) are taken from cultures immunolabeled for synaptoporin, a mossy ﬁ  bers boutons marker (A  –  C and J  –  L; and G  –  I and P  –  S, red), and MAP-2 (D  –  F 
and M  –  O; and G  –  I and P  –  S, green). Pharmacologic MMP-9 inhibition results in a dramatic decrease in the density of ectopic mossy ﬁ  bers boutons upon 
both kainate (compare B and C) and picrotoxin (compare K and L) treatment. (T) Quantitative evaluation of the effect of S24994 on either kainate- (left) or 
picrotoxin (right)-mediated sprouting, measured as the mean number of synaptoporin-positive boutons per unit volume (30,000   μ  m 
3  ) of the DG. Asterisks 
indicate statistical signiﬁ  cance (  t   test; P   <   0.05). Error bars represent SEM. (U and V) Histological effects of PTZ kindling in WT and MMP-9 KO mice. 
In normal animals (U), kindling is associated with a robust sprouting of mossy ﬁ  bers resulting in the formation of new synapses on the basal dendrites 
(stratum oriens) of CA3 pyramidal cells (white asterisks), as demonstrated using confocal imaging of synaptoporin-stained (red) specimens. In contrast, there 
is very limited response in MMP-9  –  deﬁ  cient animals (V). (W) Quantitative analysis of synaptoporin immunoﬂ  uorescence in WT versus MMP-9 KO mice. 
Asterisk indicates statistical signiﬁ  cance (Mann-Whitney   U   test; P   <   0.05). Error bars represent SEM.     JCB • VOLUME 180 • NUMBER 5 • 2008  1030
major families of synaptic adhesion proteins that have been 
strongly implicated in spine physiology (  Benson et al., 2000  ). 
Outside the brain, members of these families are known to func-
tion as either MMP substrates or receptors ( Sternlicht and Werb, 
2001  ). The role of integrins in MMP-9  –  mediated synaptic 
plasticity is strongly supported by the fi  nding that MMP-9  –
  mediated long-term potentiation depends on intact integrin func-
tion (  Nagy et al., 2006  ). Finally, as found by   Tian et al. (2007)  , 
ICAM-5 is an MMP-9 substrate involved directly in spine dy-
namics. However, besides the proposed role in structural plastic-
ity, MMP-9 could cleave and thereby activate (or inhibit) other 
molecules involved in functional plasticity. This would be simi-
lar to the action of tPA toward pro  –  brain-derived neurotrophic 
factor (  Pang et al., 2004  ). Notably, pro  –  brain-derived neuro-
trophic factor is an MMP substrate as well (  Sternlicht and Werb, 
2001  ). Finally, similar to serine proteinases (  Fernandez-Monreal 
et al., 2004  ;   Kvajo et al., 2004  ), a proteolytic action of MMP-9 
could be directly involved in some aspects of signal transmis-
sion (  Michaluk and Kaczmarek, 2007  ). 
  The second major phenomenon that we describe in this 
paper is MMP-9 action in aberrant synaptogenesis that occurs 
in the hippocampal DG days to weeks after status epilepticus 
and in the CA3 area upon kindling. Seizure-induced synapto-
genesis is not associated with pruning but with an increase in 
spine number (  Suzuki et al., 1997  ;   Isokawa, 2000  ) and/or size 
(  Represa et al., 1993  ). However, because both synapse elimina-
tion and formation likely require the same proteolytic degrada-
tion of extracellular matrix and/or adhesion molecules, it is, in 
fact, not unreasonable to hypothesize that MMP-9 is involved in 
both aforementioned phenomena. If this is true, blocking MMP-9 
at the stage of mossy fi  ber sprouting should prevent accompa-
nying spine proliferation, thereby decreasing the effi  ciency of 
synaptogenesis as, indeed, happens in KO mice (  Fig. 6  ). In con-
trast, MMP-9 overexpression at this stage could facilitate spine 
proliferation, thus stimulating formation of the new aberrantly 
positioned synapses. Experiments that aim to verify the latter 
prediction in TG rats are in progress in our laboratory. 
  We cannot exclude the possibility that under some condi-
tions, e.g. during sprouting and synaptogenesis, MMP-9 acts on 
the presynaptic domain, including axonal growth cones, as sug-
gested by some cell culture studies ( Shubayev and Myers, 2004 ). 
Finally, it is also possible that MMP-9 exerts its infl  uence on 
synaptogenesis after being released from glial cells. Indeed, the 
presence of MMP-9 in astrocytes (by double labeling with 
GFAP;   Szklarczyk et al., 2002  ) and in oligodendrocytes under 
nonstimulated conditions (  Oh et al., 1999  ) has been previously 
described. Furthermore, our ultrastructural immunolocalization, 
as well as electron microscopic in situ hybridization data 
(  Konopacki et al., 2007  ), consistently indicates the presence of 
the enzyme in the tiny astrocytic processes that ensheath the 
synapses. This allows for the fascinating possibility that several 
pools of MMP-9 contribute to the synaptic effects of this en-
zyme. The specifi  c roles of these MMP-9 reservoirs, as well as 
the modes of their regulation, are currently a subject of study in 
our laboratory. With respect to epileptogenesis, we found the high-
est level of MMP-9 expression in astrocytes at the 7th d after 
kainate, i.e., exactly when sprouting is most likely to be initiated 
MMP-9 in synaptic plasticity, concepts which are derived mainly 
from functional studies and light microscopic data (  Nagy et al., 
2006  ;   Bozdagi et al., 2007  ). 
  Our immunogold analysis of MMP-9 distribution in the 
normal hippocampus suggests that the smaller the spine, the 
more enzyme it contains (  Fig. 2  ). Interestingly, recent in vivo 
imaging studies indicate that small spines are less stable, as they 
expand and collapse at much higher rates than the large ones 
(  Matsuzaki et al., 2004  ). If the MMP is involved in releasing 
dendritic spines from constraints imposed by neighboring struc-
tures and pericellular matrix, it would be expected that small 
and more dynamic spines have more of it. Furthermore, small 
and large spine populations appear to differ from each other in 
their content of glutamate receptor subtypes. Large synapses 
(on large spines) have a higher density of AMPA than the smaller 
ones. In contrast, the density of NMDAR only shows modest 
changes with synapse size (  Takumi et al., 1999  ). Accordingly, 
long-term synaptic potentiation, which is associated with trans-
formation from silent (NMDAR only  –  containing) to fully excit-
able (NMDAR- and AMPA-containing) synapses is associated 
with the enlargement and/or reshaping of the dendritic spines 
(  Toni et al., 2001  ;   Matsuzaki et al., 2004  ). Notably, if these 
changes are precluded by the use of substances disrupting the 
F-actin cytoskeleton, potentiation does not occur (  Fukazawa 
et al., 2003  ). It is of interest in this regard that MMP-9 appears 
to be involved specifi  cally in the late phase of long-term poten-
tiation (  Nagy et al., 2006  ;   Okulski et al., 2007  ). It is possible 
that the failure of MMP-9  –  defi  cient neurons to develop long-
lasting potentiation refl  ected their inability to liberate spines from 
the milieu of pericellular matrix and cell adhesion proteins, thus 
curbing their expansion. 
  This concept would be in agreement with recent fi  ndings 
(  Tian et al., 2007  ) suggesting that cleavage of a dendritic spine 
adhesion molecule, intercellular adhesion molecule (ICAM) 5 
(telencephalin), by MMP-9 is required for activity-dependent 
spine enlargement. In line with our electron microscopic obser-
vations, this MMP-9 substrate was found to be present in small 
spines. In contrast, one could predict that mechanical constraints 
imposed by ECM and/or adhesion molecules (perhaps different 
from ICAM-5) should also impede spine pruning. Indeed, our 
results clearly indicate that MMP-9 is involved in kainate-
  induced spine pruning that shares at least some mechanisms 
with physiological spine-size transformations, including actin 
depolymerization ( Fig. 1 I ;  Hasbani et al., 2001 ). Thus, it is possi-
ble that MMP-9 facilitates elimination, as well as growth of 
spines, through a single mechanism, i.e., facilitation of spine re-
modeling. 3D electron microscopic analysis, as well as func-
tional studies in living cells, is needed to establish the precise 
relationship between spine size and MMP-9 contents. 
  At the molecular level, the mechanisms of MMP-9 action 
on spine dynamics remain poorly understood. Interestingly, 
  Oray et al. (2004)   have previously demonstrated that degrada-
tion of laminin (a principal component of brain ECM) by tissue 
plasminogen activator (tPA) directly impacts the dynamics of 
dendritic spines. MMP-9 could be involved because laminin is 
one of its substrates and tPA is known to act upstream of MMP-9 
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see   Morimoto et al., 2004  ). Thus, we believe that it is the effect 
on pathological synaptogenesis that underlies the role of MMP-9 
in the progression of epilepsy (  Fig. 7  ).    Our data indicate that the 
role of MMP-9 in aberrant synaptogenesis involves its action on 
dendritic spines (  Fig. 7  ), although further studies are needed to 
confi  rm this. 
  In a wider neurobiological context, our results place MMP-9 
in the very small group of extracellular proteinases that function 
at the synapses. These are mainly serine proteinases, such as tPA, 
neuropsin, neurotrypsin, and possibly also thrombin (for review 
see   Shiosaka, 2004  ). Among MMPs, only MMP-7 and MMP-24 
have been added to this group so far (  Bilousova et al., 2006  ; 
(  Fig. 3   and not depicted). Although MMP-9 of astrocytic origin 
may contribute to epileptogenesis, our studies in animals with 
MMP-9 overexpression (in neurons) suggest that the neuronal 
pool of MMP-9 is the more important, (Fig. S3, available at 
http://www.jcb.org/cgi/content/full/jcb.200708213/DC1). 
  A key question is whether MMP-9 infl  uence on spine dy-
namics and synaptogenesis, can explain how the enzyme facili-
tates the long-term aberrant plastic changes subserving the 
development of epilepsy. There is a near consensus that sprout-
ing, even if not absolutely required for the TLE to develop, 
powerfully stimulates epileptogenesis by generating recurrent 
excitatory circuits within the hippocampal formation (for review 
  Figure 7.       Schematic representation of presumable MMP-9 action in hippocampal epileptogenesis based on the present study.   (A) Status epilepticus induces 
dendritic spine pruning in the DG molecular layer. This is mediated by MMP-9 released from spines upon the seizures. In the absence of MMP-9, the pruning 
is attenuated, despite the presence of adequate stimulus. (B) Sprouting of mossy ﬁ  bers and aberrant synaptogenesis in the hippocampal epileptogenesis 
involve MMP-9 because both of these phenomena do not develop in the absence of the enzyme.     JCB • VOLUME 180 • NUMBER 5 • 2008  1032
  PTZ kindling 
  Mice received intraperitoneal injections of 30  –  40 mg/kg PT every other 
day consecutively for 6 wk (  De Sarro et al., 2004  ). Behavioral seizures 
were scored according to a modiﬁ  ed scale of Racine: 0, no behavioral 
changes; 1, facial movements and ear and whisker twitching; 2, myoclonic 
convulsions without rearing; 3, myoclonic convulsions with rearing; 4, 
clonic convulsion with loss of posture; and 5, generalized clonic-tonic sei-
zures or death. The brains of mice that died during experiments, as well as 
of those that were killed after the termination of experiments, were immer-
sion ﬁ  xed in 4% PFA and stored in PBS plus 0.1% sodium azide until further 
processing. Subsequent immunocytochemical procedures were performed 
as described in the previous section. 
  Rats received subcutaneous injections of 40 mg/kg PTZ every other 
day consecutively for 8 wk and were behaviorally scored using the same 
scale as for mice. In addition, another group of rats was treated to the intra-
peritoneal injections of PTZ. 
  Organotypic hippocampal culture and kainate and picrotoxin treatment 
  Cultures of hippocampal slices were prepared essentially according to 
  Jourquin et al. (2003)  . In brief, 8  –  10-d-old rat pups were decapitated and 
the hippocampi were rapidly dissected on a cold plate. 400-  μ  m-thick 
slices, perpendicular to hippocampal long axis, were cut with a tissue 
chopper and plated (three to four per well) onto Millicel-CM biomembranes 
(Millipore). The slices were cultured in a humidiﬁ  ed incubator at 37  °  C with 
5% CO  2  . Kainate was added to some for 24 h on DIV5 at a 10-  μ  M con-
centration, and the cultures were ﬁ  xed on DIV20 and processed for immuno-
cytochemical stainings. In the case of picrotoxin, the compound was 
present in culture medium at concentration of 100   μ  M throughout the 
whole culturing period (  Koyama et al., 2004  ). MMP-9 inhibition was 
achieved by growing the cultures in the presence of the speciﬁ  c MMP-9 in-
hibitor S24994 (  Hanessian et al., 2001  ) at a 100-nM concentration. The 
inhibitor was either present from the beginning (picrotoxin experiment) or 
added on DIV6 (immediately after removal of kainate). 
  Immunocytochemical procedures 
  Primary antibodies.     Two rabbit polyclonal anti  –  MMP-9 antibodies were 
used: an antibody raised against the catalytic domain of the rat MMP-9 
(Torrey Pines Biolabs, Inc.;   Szklarczyk et al., 2002  ) and an antibody raised 
against the epitope comprising the catalytic domain of the mouse enzyme 
(gift from R. Senior, Washington University, St. Louis, MO;   Betsuyaku et al., 
2000  ; see subsequent sentences for working dilutions). Both antibodies 
recognize active and latent forms of MMP-9 (  Betsuyaku et al., 2000  ; 
  Szklarczyk et al., 2002  ). The following mouse marker antibodies were used 
for double and triple immunoﬂ  uorescent stainings: anti  –  MAP-2, a dendritic 
marker, diluted at 1:200 (Millipore); anti-synaptophysin, a presynaptic 
marker, diluted at 1:20 (Dako); and anti  –  NMDAR subunit NR1 and anti  –
  GABA-AR subunits     2/3, postsynaptic markers, both diluted at 1:50 (Milli-
pore). Sprouting mossy ﬁ   ber terminals were visualized using a rabbit 
anti-synaptoporin antiserum (Synaptic Systems GmbH;   Singec et al., 2002  ) 
diluted at 1:200. 
  Light microscopic immunocytochemistry.     Light microscopic immuno-
cytochemistry was performed essentially according to   Boeckers et al. 
(1999)   in either 50-  μ  m-thick free-ﬂ  oating sections of frozen tissues or 4-  μ  m-
thick parafﬁ   n sections. The latter were used in studies of MMP-9 co-
localization with NR1 NMDAR or GABA-AR because of their permeability 
and mechanical resistance to antigen retrieval techniques. In such experi-
ments, antigen retrieval steps using 0.1% pepsin and microwaving were 
necessary and were done immediately after deparafﬁ  nization. Both kinds 
of sections were subjected to standard blocking steps, including, if needed, 
blocking of endogenous biotin (Avidin/Biotin Blocking kit; Vector Labora-
tories), followed by overnight incubation in the anti  –  MMP-9 antibody, diluted 
at 1:2,000 (R. Senior) or 1:200 (Torrey Pines Biolabs, Inc.). The detection 
of immunoreactions was performed using either species-speciﬁ  c secondary 
antibodies directly conjugated to ﬂ  uorophores or biotinylated secondary 
antibody (Vector Laboratories) followed by a ﬂ  uorophore-conjugated strep-
tavidin (Invitrogen). For double or triple stainings, we used antibodies (or 
streptavidin) conjugated to green Alexa 488 (Invitrogen), red Cy3 (Jackson 
ImmunoResearch Laboratories), or near-infrared Cy5 ﬂ  uorophores (Jackson 
ImmunoResearch Laboratories). In the case of anti  –  MMP-9, an ampliﬁ  cation 
step using biotinylated tyramide (PerkinElmer) was   included in avidin-
biotin  –  based detection. For triple immunoﬂ   uorescence with two marker 
antibodies originating from the same species, we used Zenon, a custom 
antibody-(immuno)labeling system (Invitrogen). 
  For negative controls, the primary antibody was omitted, replaced 
by a nonimmune IgG, and preabsorbed with the target antigen. In double 
  Monea et al., 2006  ; for review see   Ethell and Ethell, 2007  ). 
Notably, all these enzymes appear to be involved in some as-
pects of synaptic plasticity. Besides being engaged in normal 
processes, tPA and neuropsin were implicated in the pathogene-
sis of epilepsy (  Wu et al., 2000  ; for review see   Shiosaka, 2004  ). 
It remains to be determined if, and how, these enzymes interact 
with one another in health and disease, e.g., whether presynap-
tic tPA can function as an activator of postsynaptic MMP-9. 
  We would like to propose that our data have direct impli-
cations for human TLE. In fact, behavioral, anatomical, and 
molecular events that are associated with kainate- and kindling-
induced epileptogenesis in rats and mice largely reproduce the 
corresponding events in human TLE (  Ben-Ari, 2001  ). An es-
sential feature of the human disease captured by both models is 
aberrant synaptic plasticity. In this paper, we show that the for-
mation of aberrant synaptic networks depends on MMP-9. 
  Because these networks keep progressing, contributing to the 
increasing severity of the disease, the inhibition of this process 
might be benefi  cial at any stage. Hence, this work is not only a 
step toward understanding pathophysiology of epilepsy but also 
offers an opportunity to search for novel therapeutic approaches 
targeting the mechanisms of this disease. 
  Materials and methods 
  Animals 
  Experiments were performed on adult male Wistar rats and on adult MMP-9 
KO mice C57BL/6 strain (provided by Z. Werb, University of California, 
San Francisco, San Francisco, CA;   Vu et al., 1998  ), all according to 
the rules established by the Ethical Committee on Animal Research of the 
  Nencki Institute, based on national laws that are in full agreement with the 
European Union directive on animal experimentation. 
  Generation of MMP-9  –  overexpressing rats 
  Expression vector with autoactive MMP-9 gene driven by synapsin-1 pro-
moter were constructed in our laboratory. Plasmid DNA for microinjection 
was puriﬁ  ed using the plasmid maxiprep method. The expression cassette 
was prepared by digesting the vector DNA with PacI and XbaI enzymes and 
microinjecting it into fertilized eggs of Wistar rats (Fig. S1). All rats were 
raised and maintained under speciﬁ  c pathogen-free conditions. Genomic 
DNA was extracted from the offspring by ear biopsy and founders were 
identiﬁ  ed by PCR. The primer sequences for the PCR were 5    -AGG CGC 
GCT GAC GTC ACT CG-3     and 5    -CGC GCT CCACAG TGC GAA-3    . PCR 
reactions were performed for 30 cycles at 94  °  C for 45 s, 59  °  C for 60 s, and 
72  °  C for 60 s. Two independent lines of TG rats were generated. 
  Kainate treatment 
  Kainate (Ocean Produce) was used in both rat and mice experiments. Status 
epilepticus in rats was induced by intraperitoneal injection of 10 mg/kg 
and the animals were observed for up to 6 h, as previously described 
(  Szklarczyk et al., 2002  ). 
  The adult male mice were anesthetized with 1.3 ml/kg ketamine 
and 1.25 ml/kg xylazine and subjected to stereotactic unilateral injection 
with 1 nmol kainate in 0.3   μ  l PBS into the amygdala (  Wu et al., 2000  ). The 
coordinates of the injection were the following: bregma, 1.6 mm; medial  –
  lateral, 3.3 mm; and dorsoventral, 4.5 mm. The kainate was delivered 
over 30 s. The injection needle remained at the injection coordinates for 
another 2 min afterward to prevent reﬂ  ux of ﬂ  uid. 
  For immunocytochemical studies, animals were lethally anesthetized 
and perfused transcardially with a ﬁ  xative (4% formaldehyde, freshly de-
polymerized from PFA, in PBS; in some electron microscopic experiments, 
0.1% glutaraldehyde was added). Brains were removed, postﬁ  xed in the 
same ﬁ  xative, and either processed for parafﬁ  n embedding or cryopro-
tected and snap frozen in isopentane cooled on dry ice. 
  For biochemical studies, the brains were removed immediately after 
decapitation. From each brain, hippocampi were dissected, frozen on dry 
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of the dendritic spine linear density (per 1   μ  m of the dendritic length) was 
obtained for each group. Statistical analysis was performed using   t   test 
with the level of signiﬁ  cance deﬁ  ned as P   <   0.05. 
  Electron microscopic immunocytochemistry.     Preembedding technique 
was used according to   Boeckers et al. (1999)  . In brief, the brains were 
perfusion ﬁ  xed with 4% PFA (plus 0.1% gluteraldehyde in the case of anti  –
  MMP-9) and immunostained free ﬂ  oating just as for light microscopy, ex-
cept that repeated freezing thawing was applied at the permeabilization 
step instead of Triton X-100 and peroxidase-based detection was used with 
DAB as a chromogen. The sections were subjected to silver enhancement 
and processed for electron microscopy as previously described (  Boeckers 
et al., 1999  ). The specimens were examined under an electron microscope 
(912; Carl Zeiss, Inc.) equipped with a spectroscopic ﬁ  lter (Omega Optical) 
and a charge-coupled device camera (2K; Gatan) operating at 80 kV. 
  Postembedding procedure was performed according to   Mathiisen 
et al. (2006)  . In brief, normal Wistar rats were perfused transcardially with 
a ﬁ  xative consisting of 4% formaldehyde plus 0.1% glutaraldehyde. The 
brains were postﬁ   xed in the same ﬁ   xative, cut into 0.5  –  1.0-mm slices, 
cryoprotected, snap frozen in liquid propane (    170  °  C), and subjected to 
freeze substitution in an apparatus (EM AFS; Leica). Specimens were then 
embedded in Lowicryl HM20 resin, polymerized by UV light at     45  –  0  °  C, 
and cut into ultrathin sections. The immunoreactions consisted of sequential 
incubations with a rabbit anti  –  MMP-9 antibody (Torrey Pines Biolabs, Inc.) 
diluted at 1:50, followed by species-speciﬁ  c goat secondary antibodies 
coupled to 10-nm gold particles (GE Healthcare). The specimens were ex-
amined with an electron microscope (CM-10; Philips) at 60 kV. Images 
were acquired using either a charge-coupled device camera (1K; Soft Im-
aging System) or photographic plate camera. In the latter case, negatives 
were digitized at a 1,200-dpi resolution using a ﬂ  atbed scanner (BearPaw; 
Mustek). Final adjustments of image brightness and contrast were per-
formed using Photopaint. The sizes of, and gold particle densities within, 
various ultrastructural compartments were measured in digital micrographs 
using ImageJ (either manually or automatically). As a background, we as-
sumed the labelling over the cytoplasm of the large dendritic proﬁ  les, 
which was the lowest among all compartments. Such an estimate is likely 
to be a slight overestimate of the true background labelling (  Mathiisen et al., 
2006  ). The statistical evaluation of the labelling was performed using the 
     
2   test and observed and expected gold counts over the given compart-
ments (  Mayhew et al., 2003  ). 
  Golgi impregnation 
  Mouse brains were perfusion ﬁ  xed using 4% PFA in PBS, immersed in 5% 
potassium dichromate for 4 d, immersed in 1% silver nitrate for 4 d, em-
bedded in celloidin, and cut into 200-  μ  m-thick sections. Dendritic spines 
were counted manually in image stacks obtained using a microscope 
equipped with a motorized stage and a 60  ×   objective lens (1.25 NA). The 
counting was performed in the DG middle molecular layer (dendritic seg-
ments from at least three different cells) of four untreated and six KA-
injected animals of either genotype. In the injected mice, both affected and 
contralateral hippocampi were evaluated. The results were evaluated using 
  t   test with the level of signiﬁ  cance deﬁ  ned as P   <   0.05. 
  Isolation of synaptosomes 
  Isolation of synaptosomes was performed according to   Havik et al. (2003)  . 
In brief, frozen tissue was melted, homogenized in a glass homogenizer, 
and subjected to a series of centrifugations that yielded P1 (cell debris and 
nuclei), P2 (crude synaptosomes/mitochondria), P3 (microsomes), and S 
(cytosol) fractions. The P2 fraction was further separated into myelin, mem-
branes/Golgi, and synaptosomes using a discontinuous sucrose density 
gradient (0.8/1.0/1.2 M). 
  Gel zymography 
  The assay was performed according to   Szklarczyk et al. (2002)  , using gel-
atin  –  Sepharose 4B (GE Healthcare) and 8% polyacrylamide gel contain-
ing 5 mg/ml of gelatin (Loba Feinchemie) for enzyme puriﬁ  cation  and 
detection, respectively. Data were collected using the gel documentation 
program Gene Snap (InGenius) and Bio Imaging System (Syngen, Inc.) 
and pictures were prepared using Photoshop (Adobe). 
  In situ zymography 
  We ﬁ  rst used established techniques of in situ zymography in which a 
quenched ﬂ  uorescent substrate (DQ gelatin) is applied to fresh-frozen tissue 
sections (  Oh et al., 1999  ;   Jourquin et al., 2003  ). This approach, however, 
was totally unsatisfactory because tissue integrity was very poorly pre-
served, which was evident at the high magniﬁ  cations required to visualize 
or triple immunostainings, special care was taken to control for any possi-
ble cross-reactivity of the detection systems. 
  Fluorescent imaging.     Fluorescent specimens were examined under a 
spectral confocal microscope (TCS SP2; Leica), using 488 nm Ar, 543 nm 
GeNe, and 633 nm HeNe laser lines for the excitation of Alexa 488, Cy3, 
and Cy5, respectively. The images were acquired through the internal TCS 
SP2 detectors/photomultipliers. To avoid cross talk between the ﬂ  uoro-
phores, we carefully adjusted the spectral ranges of detectors and scanned 
images sequentially. The Plan Apo oil-immersion objective lenses were 40  ×   
(1.25 NA), 63  ×   (1.32 NA), and 100  ×   (1.4 NA). The images in   Figs. 2 (C 
and H  –  P), 5 (G  –  S), and 6 (A  –  S)   were 3D deconvolved by means of Huygens 
Professional software (Scientiﬁ  c Volume Imaging), using classical maximum 
likelihood algorithm and theoretical point-spread functions. For ﬁ  nal inspec-
tion, the images were processed using Photopaint (Corel). Brightness and 
contrast adjustments and/or Gaussian smoothing were applied, if necessary, 
to improve image clarity. Quantitative analyses of immunoﬂ  uorescence results 
included unbiased morphometric evaluation using ImageJ software (National 
Institutes of Health) and are listed in the following paragraphs. 
  We quantiﬁ  ed MMP-9  –  positive puncta colocalizing with dendrites. 
The analysis of MMP-9 (red channel)  –  MAP-2 (green channel) colocalization 
in the DG of control and kainate-treated rats was performed in single-plane 
confocal images acquired using a 63  ×   objective (oil immersion; 1.3 NA) 
with a zoom factor of four. The settings of photomultipliers were adjusted 
to obtain the maximal dynamic ranges of pixels in each channel. Because 
the intensity of MMP-9 staining (red channel) differed considerably among 
the time points, several trials were performed before the optimal value was 
found. However, even with the optimized setting, we could not avoid con-
siderable pixel saturation at 72 h after kainate. Thus, at this time point the 
sensitivity of the photomultiplier was decreased by 10%. Otherwise, identi-
cal scanning conditions were maintained during all image acquisition ses-
sions, including the constant distance of the focal plane to the surface of 
the section (7   μ  m). In each brain, three different random focal planes were 
scanned in each of the molecular layer subdivisions, inner, medial, and 
outer. We designed a macro within ImageJ that automatically segmented 
areas in which red and green signals colocalized. The colocalization was 
considered to occur if, at a given pixel, both signals were above the thresh-
old values (red, 115; green, 70) and their ratio of signal intensities was 
  >  0.33. Using an unbiased counting frame (  Gundersen, 1978  ), at each 
time point we estimated the mean number of colocalizing objects per unit 
area of the tissue, the ratio of the number of colocalizing objects to the 
number of all MMP-9  –  immunoreactive objects, and the mean ﬂ  uorescence 
intensity of the colocalizing objects, deﬁ  ned as the product of the mean 
area of the colocalizing objects times the mean brightness (red channel). 
At least four animals were analyzed at each time point. Statistical analysis 
was performed using Kruskall-Wallis ANOVA with the level of signiﬁ  cance 
deﬁ  ned as P   <   0.05. 
  We quantiﬁ  ed mossy ﬁ  ber synapses in hippocampal organotypic 
cultures. The measurements were performed in cultures (prepared as de-
scribed in Organotypic hippocampal culture...) stained with the anti-synapto-
porin antibody followed by the anti  –  rabbit Cy3 (Jackson ImmunoResearch 
Laboratories) secondary. The ﬂ  uorophore was excited with 543 laser light, 
and stacks of 7  –  25 confocal planes were acquired using a 40  ×   objective 
(oil immersion; 1.25 NA). Three different ﬁ  elds covering the area of gran-
ule cell plus molecular layers were acquired from each culture. The stacks 
were analyzed using an automatic 3D analysis function of ImageJ at the 
threshold of 101. The results were calculated as numbers of mossy ﬁ  ber 
boutons per 30,000   μ  m 
3  . Statistical analysis was performed using   t   test 
with the level of signiﬁ  cance deﬁ  ned as P   <   0.05. 
  We performed confocal analysis of dendritic spine density. Den-
dritic spines were identiﬁ   ed using a guinea pig anti-ProSAP2/Shank 
antibody and a PSD marker (  Boeckers et al., 1999  ) together with rhodamine-
phalloidin (Sigma-Aldrich), which binds to spine F-actin, or with a guinea 
pig anti-drebrin antibody (Fitzgerald). The measurements were per-
formed in single-plane confocal images acquired using a 100  ×   objective 
(oil immersion; 1.4 NA) with a zoom factor of four. Spines (rhodamine, red 
channel) and dendrites (Cy5, blue channel) were scanned sequentially us-
ing laser lines of 543 and 633 nm, respectively. The settings of photomulti-
pliers were adjusted to obtain the maximal dynamic ranges of pixel 
intensities in each channel. Identical scanning conditions were maintained 
during all image acquisition sessions. In each section the position of focal 
plane was set at the level of maximum intensity of the blue channel. From 
each hippocampus, three different random ﬁ  elds were scanned within the 
middle molecular layer. The number of spines and the total length of den-
dritic segments within each unbiased counting frame were measured auto-
matically using a custom-designed ImageJ macro. As a result, an estimate JCB • VOLUME 180 • NUMBER 5 • 2008  1034
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individual dendrites. To overcome this problem, we took advantage of the 
technique widely used in electrophysiological studies, in which slices of 
fresh brain are cut and subsequently maintained at conditions that allow 
preservation of at least some features of the living tissue for a deﬁ  nite time. 
The reﬁ  ned procedure used 150-  μ  m-thick fresh brain vibratome sections 
that were placed in tissue culture wells and covered with a solution of 
50 mg/ml DQ gelatin (Invitrogen) diluted in artiﬁ  cial cerebrospinal ﬂ  uid of 
the following composition: 117 mM NaCl, 1.2 mM MgSO  4  , 4.7 mM KCl, 
2.5 mM CaCl  2  , 25 mM NaHCO  3  , 1.2 mM NaH  2  PO  4  , and 10 mM glucose. 
The specimens were kept for 2 h at 37  °  C with 5% CO  2   in a tissue culture 
incubator, rinsed twice with PBS for 10 min at RT, and ﬁ  xed overnight with 
4% PFA in PBS. Subsequent coimmunostaining for visualization of den-
drites was performed essentially as described in Light microscopic immuno-
cytochemistry, except that the step of the slice dehydration-rehydration 
using acetone/methanol solution was included at the beginning of the 
staining to help tissue permeabilization. The examination of the sections un-
der the confocal microscope indicated that the procedure gave acceptable 
results in terms of both retaining enzymatic activity and tissue integrity. 
  Online supplemental material 
  Fig. S1 presents the outline, as well as the biochemical validation, of the 
procedure of making TG rats that overexpress MMP-9. Fig. S2 shows 
confocal micrographs demonstrating colocalization of MMP-9 and the 
dendritic spine marker drebrin. Fig. S3 shows low power confocal micro-
graphs of the hippocampal organotypic cultures demonstrating the effect 
of pharmacological inhibition of MMP-9 on kainate-induced mossy ﬁ  bers 
sprouting (in both supra- and infragranular layer [  Frotscher et al., 2000  ]). 
Online supplemental material is available at http://www.jcb.org/cgi/
content/full/jcb.200708213/DC1. 
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